comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 23:57:11 - browse：2616

Aduhelm package — Jessica Rinaldi/The Boston Globe

Biogen is giving up its ownership of Aduhelm, the Alzheimer’s disease treatment whose 2021 approval led to scrutiny and outrage, turning the page on a tempestuous chapter in the company’s long history.

Neurimmune, the Swiss company that invented Aduhelm, will regain full rights to the intravenous medicine, Biogen said Wednesday. Biogen will also terminate an ongoing clinical trial meant to prove the treatment’s benefits for patients in the early stages of Alzheimer’s.

“When searching for new medicines, one breakthrough can be the foundation that triggers future medicines to be developed,” Biogen CEO Christopher Viehbacher said in a statement. “Aduhelm was that groundbreaking discovery that paved the way for a new class of drugs and reinvigorated investments in the field.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Kristina Burow of ARCH Venture Partners shares her next big bets STAT

focus

WSS

A Q&A with Aletha Maybank, AMA’s chief health equity officer

FDA panel issues narrow recommendation for Covid vaccine booster doses

RaDonda Vaught to speak at CommonSpirit event on patient safety

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

House looks to weaken Medicare negotiation

Police still searching for prisoner who escaped from NYC hospital

leisure time

comprehensive

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Activists slam private health insurers over coverage restrictions

FDA does about

Medical records are filled with copy

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Medical leaders decry Supreme Court decision on affirmative action

AstraZeneca loses challenge to Medicare drug price negotiation

Trump demands the U.S. pay no more for drugs than other countries … again

American woman, child freed after being kidnapped in Haiti last month

hotspot

How to address the problem of discarded donor organs

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

South Korea throws huge K

House looks to weaken Medicare negotiation

International team creates first chimeric human

Maui's cultural, historic landmarks damaged in the devastating wildfires

leisure time

knowledge

focus

focus